Guangzhou, China

Ang Zha

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Santolecan Pharmaceuticals LLC. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ang Zha. Retrieved from https://idiyas.com/inventor/ang-zha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ang Zha: Innovator in Drug Delivery Systems

Introduction

Ang Zha is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy of drug formulations through novel conjugates.

Latest Patents

Ang Zha holds a patent for "Taxane-lipid-polysaccharide dual conjugates, preparation methods thereof and uses thereof." This invention pertains to a group of taxane-lipid-polysaccharide dual conjugates, which are designed to improve drug delivery. The patent outlines a process for the preparation of these conjugates and their applications in pharmaceutical compositions. The invention also includes a series of intermediates for the preparation of these dual conjugates, emphasizing their potential as effective drug delivery vehicles. He has 1 patent to his name.

Career Highlights

Ang Zha is currently associated with Santolecan Pharmaceuticals LLC, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to advancing drug delivery technologies that can significantly impact patient care.

Collaborations

Ang Zha collaborates with notable colleagues, including Jinghua Hu and Xiaohai Li, who contribute to his research and development efforts.

Conclusion

Ang Zha's innovative work in drug delivery systems exemplifies the importance of research and development in pharmaceuticals. His contributions are paving the way for more effective treatments and improved patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…